CD8 Antilichaam [H35-17.2] (PE)
Gecertificeerd

CD8 Antilichaam [H35-17.2] (PE)

Catalog #: 76-720
Maat: 0.05 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

The H35-17.2 monoclonal antibody specifically reacts the mouse cd8 beta, a 32 kDa chain also known as Ly-3 and Lyt-3. CD8 is a T cell surface antigen co-receptor that interacts with MHC class I molecules on antigen presenting cells. It is expressed as a heterodimer with the alpha cd8 chain. The H35-17.2 antibody blocks T cell-mediated cytolysis of allogeneic lymphoma cells.

NCBI Gene ID

12526

Swiss Prot

P10300

Host

• Rat

Reactivity

Mouse

Clonality

• Monoclonal

Clone

H35-17.2

Conjugation

PE

Type

Primary Antibodies

Field of Research

Immunology

Purification

The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.

Concentration

Batch dependent

Buffer

Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

The product should be stored undiluted at 4˚ C and should be protected from prolonged exposure to light. Do not freeze.

Fragment

Rat IgG2b, kappa

Specificity

The H35-17.2 monoclonal antibody specifically reacts the mouse cd8 beta, a 32 kDa chain also known as Ly-3 and Lyt-3.

Symbol

Cd8b1

NCBI Official Name

CD8 antigen, beta chain 1

NCBI Organism

Mus musculus

Background Reference 01

Driessens, M. H., Van Hulten, P., Zuurbier, A., La Riviere, G., Roos, E. (1996) . Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18. Evidence that the LFA-1 binding sites for ICAM-1, -2, and-3 are distinct.Journal of leukocyte biology,60 (6), 758-765.

Background Reference 02

Zahalka, M. A., Naor, D. (1994) . -beta-2-lntegrin dependent aggregate formation between LB T cell lymphoma and spleen cells: assessment of correlation with spleen invasiveness.International immunology,6 (6), 917-924.

Background Reference 03

Isobe, M., Yagita, H., Okumura, K., Ihara, A. (1992) . Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.Science,255 (5048), 1125-1127.

Other Product Names

Cd8b, Ly-3, Ly-C, Lyt-3, Cd8b1

Tested Applications

Flow

Physical Properties

Liquid

Beschrijving

CD8 Antilichaam [H35-17.2] (PE) Beschikbaar in 0.05 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamCD8 Antilichaam [H35-17.2] (PE)
Categorie
Beschikbare grootte0.05 mg
Catalogusnummer76-720